OneMedNet Corp. (ONMD) intrinsic value & 10-year financials
OneMedNet Corp. (ONMD) has a Graham intrinsic value of $0.51 per share. At $4.51 on Oct 17, 2026, the stock trades 784% above that value. Over the last 5 fiscal years revenue grew 5.6% a year to $1.4M, with an average return on invested capital of 79.9%.
- Graham intrinsic value
- $0.51
- Share price (Oct 17, 2026)
- $4.51
- Price vs Graham value
- 784% above
- Market cap
- $200.9M
- Revenue (FY2025)
- $1.4M
- Revenue growth (5-yr CAGR)
- 5.6%
- ROIC (10-yr avg)
- 79.9%
- Free cash flow (FY2025)
- -$7.5M
ONMD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.4M | -$2.8M | -$0.06 | -$7.5M | -711.3% | 130.5% |
| FY2024 | $643.0K | -$10.1M | -$0.36 | -$7.0M | -1493.8% | 81.9% |
| FY2023 | $1.0M | -$23.2M | -$0.98 | $8.2M | -819.7% | 69.9% |
| FY2022 | $1.2M | $336.7K | $0.03 | -$998.6K | -460.6% | 37.2% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
OneMedNet Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
OneMedNet Corp has earned high returns on invested capital, averaging 79.9% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
OneMedNet Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, OneMedNet Corp is modeled at 5.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.51 per share.